SANOFI |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+0.18% | +1.27% |
| 08:04am | Sanofi: approval of Dupixent for COPD in the EU | CF |
| 07:45am | Sanofi obtains EU approval for Dupixent | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 816B | ||||||
| 634B | ||||||
| 351B | - | - | - | - | ||
| 323B | ||||||
| 293B |
- Stock Market
- Equities
- SAN Stock
- GCVRZ Stock
- Charts Sanofi
- Sector Chart
